SCENIHR has launched a public consultation on an update to its 2008 opinion concerning the safety of DEHP when used as a plasticiser in polyvinylchloride (PVC) medical devices, particularly for “at-risk” groups including neonates. The health effects of a number of alternative plasticisers are also assessed. SCENIHR concludes that the replacement of DEHP in medical devices should be considered against the efficacy of treatment, and the toxicological profile and leaching potential of any alternative materials, for which it notes “there is a strong need to develop and collect data on the toxicological profile and exposure”.
European Commission. Scientific Committee on Emerging and Newly Identified Health Risks. Preliminary opinion on the safety of medical devices containing DEHP-plasticized PVC or other plasticizers on neonates and other groups possibly at risk (2014 update). The SCENIHR adopted this opinion on 24 September 2014, for public consultation. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_047.pdf
The above items were taken from the December 2014 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here)News Home Guest Write For Us? Contact Us